In addition, analyses of clinical samples revealed that SHARPIN mRNA expression was significantly higher (p < 0.005) in synovial sarcoma (n = 40) than in normal tissue (n = 10) (Figure 3B). The gene discussed is SHARPIN; the disease is synovial sarcoma.